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Abstract
This article is a case report of a high grade, radio-induced, breast malignant fibrous histiocytoma
(undifferentiated high grade pleomorphic sarcoma), which developed in a 44-year old female, seven
years after breast conservative surgery and radiotherapy for a T1N0M0 invasive left breast ductal
carcinoma. The sarcoma presented as a fast growing tumour, 9.5 cm in the largest diameter, with
skin, left breast, chest wall muscle and rib invasion.
Neoadjuvant chemotherapy was performed with epirubicin and ifosfamide. Extended radical
surgery according to oncological standards and soft tissue reconstruction were carried out.
Despite bad prognostic features of high grade and large invasive sarcoma, the patient is currently,
after 44 months of follow up, without local recurrence, or metastases, exceeding the 12.8-month
mean recurrence period and mortality rate for these tumours larger than 8.1 cm (± 1.2 cm) as
described in the literature.
Background
External radiotherapy has now become standard follow-
ing breast conservative surgery. Despite this, the occur-
rence of radiation-induced sarcoma is still reported as a
rare complication, with incidence ranging from 0.008% to
0.48% [1-4]. Radio-induced breast sarcoma has a poor
prognosis with a 68% recurrence rate after resection, and
mean recurrence period of 12.8 months (median = 7.5
months) [5]. Regarding survival, reported mortality rate is
67.6% at a mean of 61.4-month follow-up [5], with a five-
year survival rate ranging from 27.7% to 36% [4,6,7].
Angiosarcoma, malignant fibrous histiocytoma and oeste-
osarcoma are the most frequent histopathogical types of
radiation-induced breast sarcoma published in the Eng-
lish-language literature [4-6,8,9].
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Case report
A 44-year-old woman was admitted in May 2002 at our
unit with a fast growing tumour in her left breast. Clinical
evaluation revealed a lesion more than 10 cm in its maxi-
mum diameter, occupying the whole breast. The tumour
had grossly infiltrated the skin and was fixed to the chest
wall (figure 1 and 2). Incisional biopsy revealed the
tumour to have high-grade spindle cell morphology and
negative epithelial immunohistochemical markers, com-
patible with sarcoma (figure 3).
Subsequent thoracic magnetic resonance imaging (MRI)
revealed an expansive lesion of left breast and chest wall
origin, infiltrating the skin and invading the pectoralis
major and minor muscles, and the 7th – 9th ribs (figures
4 and 5). Thoracic and abdominal Computed Tomogra-
phy did not identify any metastases.
The patient had been treated seven years earlier for a left
breast ductal carcinoma T1N0M0 invasive, and well dif-
ferentiated. The treatment had consisted of a local 1.5 cm
tumour excision in the left superior quadrant of the left
breast with ipsilateral axillary lymph node dissection. His-
tological examination of the 29 lymph nodes excised was
negative for malignant cells. Post-operative external beam
radiotherapy was initiated 27 days after the surgery. It was
applied to the remaining left breast, left axilla, supracla-
vicular fossa and internal mammary chain lymph nodes.
The total 55 Gy radiation dose was delivered in 25 frac-
tions, during a 5-week period, using a 3-field technique, in
a Cobalt unit. The treatment ended in August 1994 with
no adjuvant chemotherapy, and she had remained dis-
ease-free.
Neoadjuvant treatment for the high-grade sarcoma was
initiated in June 2002, together with intravenous epiru-
bicin, in a bolus dose of 60 mg/m2 from day D1 to D2,
Radio-induced breast sarcoma, front view Figure 1
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and ifosfamide, intravenous dose of 1800 mg/m2 from
day D1 to D5 [9,10]. Anaemia, leucopoenia, nausea, vom-
iting and diarrhoea were the main adverse effects, with
decreased leukocyte counts to 400 per mm3. Four sessions
of chemotherapy were taken with 21-day intervals. At the
end of the second session, clinical evidences of approxi-
mately 20% decrease in tumour diameter and resolution
of the adjacent satellite lesions were observed.
Preoperative lateral view Figure 2
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Surgery was performed in October 31st, 2002, according
to oncological standards. Total radical mastectomy with
chest wall en bloc resection was carried out. The oncolog-
ical principle was to totally excise the tumour-infiltrated
tissue with cancer cell-free margins of at least 2 cm. A large
portion of the skin extending from the sternum to the left
axilla and from the left clavicle to the 10th left rib was
resected. As the dissection was taken deep, the breast, pec-
toralis major and minor muscles, part of the serratus ante-
rior muscle and the 7th to 9th ribs and pleura were removed
en bloc (figure 6 and 7). A large soft tissue and chest wall
defect required surgical reconstruction.
The principles of chest wall reconstruction were to pro-
vide obliteration of intra-thoracic dead space, skeletal sta-
bilization and adequate soft tissue coverage. A 20 × 10 cm
prolene mesh, covered by transposition and rotation of
well vascularized regional muscle flaps, was used for skel-
etal stabilization. The mobilized muscles were the contral-
ateral pectoralis major, keeping free the serratus anterior
and the ipsilateral latissimus dorsi muscles. Adequate soft
tissue coverage was achieved advancing and rotating an
extensive thoracic-abdominal fasciocutaneous flap (figure
8). The reconstruction maintained normal respiration
physiology, protected thoracic viscera and provided soft
tissue coverage.
Histopathological examination of the surgical specimen
confirmed a 9.5 × 9.0 × 8.5 cm high-grade breast and chest
wall sarcoma invading the skin anteriorly and three ribs,
pectoralis muscles and portion of the serratus muscle pos-
teriorly. Histological evaluation revealed marked cytolog-
ical and nuclear pleomorphism, often with bizarre
tumour giant cells, occasionally multinuclear, combined
with spindle cells and necrosis. Immunohistochemical
examination showed tumour cells were reactive for
vimentin. Stains were negative for cytokeratin (AE1/AE3),
actin (HHF-35, IA4), calponin, myo-D1, S100 protein,
CD34 and CD31. These immunohistochemical and his-
topathological findings allowed a diagnosis of undifferen-
tiated high-grade pleomorphic sarcoma (pleomorphic
malignant fibrous histiocytoma).
Malignant fibrous histiocytoma (hematoxylin and eosin section) Figure 3
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Presence of 20% of necrosis in the surgical specimen was
an important finding of the histological examination,
which had not been observed at incisional biopsy per-
formed prior to neoadjuvant chemotherapy (figure 9).
Thorax Magnetic Resonance Imaging (MRI) showing tumor invading anteriorly the skin and posteriorly ribs and pleura Figure 4
Thorax Magnetic Resonance Imaging (MRI) showing tumor invading anteriorly the skin and posteriorly ribs and pleura.
Sagittal view of thorax MRI, tumor invading breast and chest wall Figure 5
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The patient is currently in good health with no recurrence
and breast reconstruction is being planned. Discussion
It is well known that ionizing radiation can induce sar-
coma [1,8]. Cahan et al in 1948 defined the criteria for
post-radiation bone sarcoma [12]. The requirements are:
(a) evidence of an initial distinct malignant tumour differ-
ent from the subsequent sarcoma, (b) development of the
Presence of necrosis in 20% of the surgical specimen after  neoadjuvant chemotherapy Figure 9
Presence of necrosis in 20% of the surgical specimen after 
neoadjuvant chemotherapy.
Ribs resection in the posterior view of the surgical specimen Figure 7
Ribs resection in the posterior view of the surgical specimen.
Anterior view of the surgical specimen showing skin invasion Figure 6
Anterior view of the surgical specimen showing skin invasion. Result of radical surgical resection with oncological standards  and reconstruction Figure 8
Result of radical surgical resection with oncological standards 
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second malignant tumour in an irradiated field, (c) long
interval between irradiation and development of sarcoma,
and (d) histological confirmation of sarcoma [9]. This
case report fulfils all these criteria.
Prognostic factors leading to poor outcome in breast
radio-induced sarcomas are large and high-grade
tumours, as described previously. In a study with 34 indi-
viduals with localized disease at the time of the surgery,
tumour mean diameters of 7.9 cm ± 0.9 (n = 11) had
malignant recurrences, with 12.8-month ± 10.6 (median
= 7.5 months) mean recurrence period, while those with
mean diameters of 3.3 cm ± 1.5 (n = 4) did not (p = 0,021)
[5]. Patients who were alive without evidence of cancer
had a mean tumour size of 4.2 cm ± 0.77, whereas those
who died of the disease had mean tumour size 8.1 cm ±
1.2 tumours (p = 0.030) [5]. In a series of 80 radio-
induced sarcoma patients, composed of 42% of breast
treated patients, histological grade 2 sarcomas had a 5-
year survival rate of 62%, compared to 19% survival rate
in grade 3 (high grade) sarcomas (p < 0.01) [8].
The unsatisfactory results of recurrence and mortality rates
of large and high grade radio-induced breast and chest
wall sarcomas may have led oncologists worldwide not to
consider extended surgical resection. Reasons include lit-
erature evidence of unfavourable prognosis, patient mor-
bidity caused by the amount of removed surgical tissue.
Palliative chemotherapy has been the mainstay of man-
agement in these situations. This case report indicates that
patients with large and high-grade radiation-induced
breast sarcomas can be offered a curative treatment. The
reported patient has already survived 44 months of fol-
low-up without evidence of malignancy, despite the pres-
ence of bad prognostic features, surpassing the recurrence
range period described in the literature for patients with
high-grade and large (9.5 cm) tumours [5].
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